200230 — Telcon RF Pharmaceutical Balance Sheet

0.000.00%

Last trade - 00:00

TechnologySpeculativeSmall CapValue Trap

Annual balance sheet for Telcon RF Pharmaceutical, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	R2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Interim Report/A	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	15,888	24,730	23,195	11,963	10,519
Net Total Accounts Receivable
Net Total Receivables	12,381	10,768	9,747	6,455	16,284
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	32,593	40,257	37,357	23,127	32,989
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	7,107	8,417	9,320	8,038	8,468
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	129,487	185,053	168,030	119,255	140,415
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	14,603	90,921	60,113	34,329	34,924
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	17,632	93,714	61,450	35,132	35,956
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	111,855	91,339	106,580	84,123	104,459
Total Liabilities & Shareholders' Equity	129,487	185,053	168,030	119,255	140,415
Total Common Shares Outstanding